Clinical Trials Logo

Clinical Trial Summary

The purpose of this investigation is to see if the TRICENTO Valved Stent Graft implant reduces tricuspid regurgitation (TR) and improves the symptoms and quality of life in 15 participants with carcinoid heart disease, and who are not able to have a new valve via a surgical procedure.

Clinical Trial Description

After being informed about the study and the potential risks and benefits, participants who provide written consent will be screened to make sure they fulfil the study entry requirements. This will involve a detailed medical history, a CT and an echo scan. Once it is agreed that the participant is suitable for the study, a custom-made TRICENTO valve is prescribed and made. Participants need to be admitted to hospital for the TRICENTO device to be implanted. Before the device is implanted the participant will have further tests and measurements completed eg ECG, a Cardiac MRI, physical measurements such as height, weight and blood pressure, blood tests, questionnaires and measuring how far they can walk in 6 minutes. The device is implanted in a cath lab procedure which should take about 30-60 minutes in total. Participants should be discharged from hospital about 2-3 days later after recovery and further echocardiogram, blood tests and questionnaires. Follow up visits are at 1 month and 6 months after the procedure. The following measurements such as an ECG, echocardiogram, and physical measurements (height, weight and blood pressure), some blood tests, questionnaires and measuring how far they can walk in 6 minutes will be repeated at 1 month and at 6 months after the procedure. A cardiac MRI will also be repeated at 6 months after the procedure. All these tests are to measure whether the TRICENTO valve improves the participant's heart function, symptoms and quality of life. ;

Study Design

Related Conditions & MeSH terms

NCT number NCT05064514
Study type Interventional
Source Queen Mary University of London
Contact R&D Governance Administrator
Phone +44 (0) 20 7882 6826
Email [email protected]
Status Not yet recruiting
Phase N/A
Start date September 2021
Completion date August 2025

See also
  Status Clinical Trial Phase
Completed NCT03144024 - Comparison of Rigid Annuloplasty Ring With a Band in the Correction of Secondary Tricuspid Insufficiency N/A
Not yet recruiting NCT05006443 - Staging Classification of Severe Tricuspid Regurgitation Using Novel Cardiac Imaging Techniques N/A
Recruiting NCT04665583 - Prehab Prior to Undergoing Tricuspid Intervention
Not yet recruiting NCT04100720 - Early Feasibility Study of the Cardiovalve System for Tricuspid Regurgitation N/A
Completed NCT02981953 - TRI-REPAIR: TrIcuspid Regurgitation RePAIr With CaRdioband Transcatheter System N/A
Recruiting NCT04433065 - TTVR Early Feasibility Study N/A
Recruiting NCT04653428 - German Registry for Transcatheter Tricuspid Valve Interventions
Not yet recruiting NCT04905017 - Trisol System EFS Study N/A
Completed NCT02644616 - The Safety and Efficacy of Tolvaptan for Patients With Tricuspid Regurgitation and Right Heart Failure After Left Heart Valves Replacement Phase 4
Active, not recruiting NCT02675244 - Evaluating the Benefit of Concurrent Tricuspid Valve Repair During Mitral Surgery N/A
Completed NCT01093001 - Tricuspid Regurgitation Study Phase 4
Recruiting NCT04339192 - Minimally Invasive Tricuspid Surgery vs Medical Treatment for Severe TR N/A
Completed NCT00665301 - Cardiac Output Pulmonary Arterial Catheter Compared to FloWave™ 1000 N/A
Recruiting NCT00419354 - The Impact of Right Ventricular Pacing on Tricuspid Regurgitation N/A
Recruiting NCT04782908 - Hemodynamic Implications of Transcatheter Tricuspid Valve Repair in HFpEF Patients N/A
Not yet recruiting NCT04936802 - Safety and Feasibility of the Transcatheter Tricuspid Valve Repair System (Trialign) N/A
Recruiting NCT04400513 - Development of an Algorithm to Differentiate Heart Murmurs Using Electronic Stethoscopes
Recruiting NCT04289870 - Innoventric Trillium™ Stent Graft First-in-Human (FIH) Study N/A
Completed NCT02098200 - Percutaneous Treatment of Tricuspid Valve Regurgitation With the TriCinch System™ Phase 1
Recruiting NCT04570163 - Berlin Registry of Right Heart Interventions